000 | 01508 a2200469 4500 | ||
---|---|---|---|
005 | 20250517233737.0 | ||
264 | 0 | _c20190722 | |
008 | 201907s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood-2018-06-859405 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrennan, Margs S | |
245 | 0 | 0 |
_aHumanized _h[electronic resource] |
260 |
_bBlood _c10 2018 |
||
300 |
_a1573-1583 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aThiophenes _xpharmacology |
700 | 1 | _aChang, Catherine | |
700 | 1 | _aTai, Lin | |
700 | 1 | _aLessene, Guillaume | |
700 | 1 | _aStrasser, Andreas | |
700 | 1 | _aDewson, Grant | |
700 | 1 | _aKelly, Gemma L | |
700 | 1 | _aHerold, Marco J | |
773 | 0 |
_tBlood _gvol. 132 _gno. 15 _gp. 1573-1583 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2018-06-859405 _zAvailable from publisher's website |
999 |
_c28761331 _d28761331 |